05/2009 - Državni zavod za intelektualno vlasništvo

1938 HR - Patenti - Hrvatski glasnik intelektualnog vlasništva 16, 2009, 5, 1863 – 2065(31) 06015439 (32) 25.07.2006. (33) EP(54) PROCESS FOR THE PREPARATION OF LEVETIRACETAM(71) ZaCh System S.p.A., Via Lillo del Duca, 10, 20091 Bresso (Milano),IT(72) FORCATO, Massimiliano, Via Porto, 25/B, I-35030 GalzignanoTerme (PD), ITMICHIELETTO, Ivan, Via Monte Santo 3, I-31100 Treviso, ITMARAGNI, Paolo, Via Grioli 32, I-46030 Virgilio (MN), ITMASSACCESI, Franco, Via Trento 1, I-36045 Lonigo (VI), ITCOTARCA, Livius, Via Mercato, 18, I-33052 Cervignano Del Friuli,IT(54) POLYMORPHS OF ATORVASTATIN SODIUM AND MAGNESIUMSALTS(71) KRKA, tovarna zdravil, d.d., Novo mesto, Smarjeska cesta 6, 8501Novo mesto, SI(72) KROSELJ, Vesna, Staro sejmisce 47, 8310 Sentjernej, SISMRKOLJ, Matej, Orehovica 4, 1411 Izlake, Zagorje ob Savi, SIOSOLNIK, Renata, Vavta vas 16, 8351 Straza, SITIHI, Jaroslav, Ulica Slavka Gruma 36, 8000 Novo Mesto, SIZUPET, Rok, Janeza Rozica 6, 1000 Ljubljana, SISTIMAC, Anton, Ulica Bratov Ucakar 12, 1000 Ljubljana, SI(51) MKPC07D 207/273 (2006.01) (97) EP 2049477 *A61K 31/4025 (2006.01)C07D 403/12 (2006.01)(86) PCT/US2007074438 26.07.2007.(96) EP 07799831.8 26.07.2007.(87) WO2008014381, 31.01.2008. 200805(97) EP 2049477, 22.04.2009. 200917, En(31) 834235 P (32) 28.07.2006. (33) US896026 P 21.03.2007. US782704 25.07.2007. US(54) MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY,CRYSTALLINE FORMS AND PROCESS(71) Bristol-Myers Squibb Company, Route 206 and Province LineRoad, Princeton, NJ 08543-4000, US(72) YANG, Michael G., c/o Bristol-Myers Squibb Company Route 206 &Province Line Road, Princeton, New Jersey 08543, USCHERNEY, Robert J., c/o Bristol-Myers Squibb Company Route206 & Province Line Road, Princeton, New Jersey 08543, USEASTGATE, Martin G., c/o Bristol-Myers Squibb Company 1Squibb Drive, New Brunswick, New Jersey 08903, USMUSLEHIDDINOGLU, Jale, c/o Bristol-Myers Squibb Company 1Squibb Drive, New Brunswick, New Jersey 08903, USPRASAD, Siva Josyula, c/o Bristol-Myers Squibb Company 1Squibb Drive, New Brunswick, New Jersey 08903, USXIAO, Zili, c/o Bristol-Myers Squibb Company Route 206 &Province Line Road, Princeton, New Jersey 08543, US(51) MKPC07D 207/28 (2006.01) (97) EP 2049478 *C07D 401/06 (2006.01)A61K 31/4015 (2006.01)A61K 31/402 (2006.01)A61P 25/28 (2006.01)A61P 29/00 (2006.01)(86) PCT/EP2007056675 03.07.2007.(96) EP 07787001.2 03.07.2007.(87) WO2008003697, 10.01.2008. 200802(97) EP 2049478, 22.04.2009. 200917, En(31) 0613473 (32) 06.07.2006. (33) GB0622825 15.11.2006. GB0705263 19.03.2007. GB0711439 13.06.2007. GB(54) SUBSTITUTED N-PHENYLMETHYL -5-OXO-PROLINE-2-AMIDESAS P2X7-RECEPTOR ANTAGONISTS AND THEIR METHODSOF USE(71) Glaxo Group Limited, Glaxo Wellcome House Berkeley Avenue,Greenford Middlesex UB6 0NN, GB(72) CHAMBERS, Laura, J, GlaxoSmithKline New Frontiers SciencePark South Third Avenue, Harlow Essex CM19 5AW, GBGLEAVE, Robert, GlaxoSmithKline New Frontiers Science ParkSouth Third Avenue, Harlow Essex CM19 5AW, GBSENGER, Stefan, GlaxoSmithKline Gunnels Wood Road,Stevenage Hertfordshire SG1 2NY, GBWALTER, Daryl, Simon, GlaxoSmithKline New Frontiers SciencePark South Third Avenue, Harlow Essex CM19 5AW, GB(51) MKPC07D 207/34 (2006.01) (97) EP 2049479 *A61K 31/40 (2006.01)A61P 3/00 (2006.01)(86) PCT/EP2007053687 16.04.2007.(96) EP 07728152.5 16.04.2007.(87) WO2007118873, 25.10.2007. 200743(97) EP 2049479, 22.04.2009. 200917, En(31) 200600098 (32) 14.04.2006. (33) SI(51) MKPC07D 209/08 (2006.01) (97) EP 2054383 *C07D 213/38 (2006.01)C07D 213/56 (2006.01)C07D 217/02 (2006.01)C07D 231/12 (2006.01)C07D 233/64 (2006.01)C07D 233/70 (2006.01)C07D 233/72 (2006.01)C07D 249/06 (2006.01)C07D 249/10 (2006.01)C07D 271/06 (2006.01)C07D 275/02 (2006.01)C07D 277/32 (2006.01)C07D 285/10 (2006.01)(86) PCT/US2007075422 08.08.2007.(96) EP 07840764.0 08.08.2007.(87) WO2008021849, 21.02.2008. 200808(97) EP 2054383, 06.05.2009. 200919, En(31) 821845 P (32) 09.08.2006. (33) US(54) NOVEL COMPOUNDS AS ANTAGONISTS OR INVERSEAGONISTS AT OPIOID RECEPTORS(71) SmithKline Beecham Corporation, One Franklin Plaza P.O. Box7929, Philadelphia, PA 19101, US(72) COWAN, David John, GlaxoSmithKline Corporate IntellectualProperty Dept. Five Moore Drive PO Box 13398, Research TrianglePark, NC 27709, USLARKIN, Andrew Lamont, GlaxoSmithKline Corporate IntellectualProperty Department Five Moore Drive PO Box 13398, ResearchTriangle Park, NC 27709, USZHANG, Cunyu, GlaxoSmithKline Coporate Intellectual PropertyDept. Five Moore Drive PO Box 13398, Research Triangle Park, NC27709, USMUSSO, David Lee, GlaxoSmithKline Corporate IntellectualProperty Dept. Five Moore Drive PO Box 13398, Research TrianglePark, NC 27709, USGREEN, Gary Martin, GlaxoSmithKline Corporate IntellectualProperty Dept. Five Moore Drive PO Box 13398, Research TrianglePark, NC 27709, USCADILLA, Rodolfo, GlaxoSmithKline Corporate Intellectual PropertyDept. Five Moore Drive PO Box 13398, Research Triangle Park, NC27709, USSPEARING, Paul Kenneth, GlaxoSmithKline Corporate IntellectualProperty Dept. Five Moore Drive PO Box 13398, Research TrianglePark, NC 27709, USBISHOP, Michael Joseph, GlaxoSmithKline Corporate IntellectualProperty Dept. Five Moore Drive PO Box 13398, Research TrianglePark, NC 27709, USSPEAKE, Jason Daniel, GlaxoSmithKline Corporate IntellectualProperty Dept. Five Moore Drive PO Box 13398, Research TrianglePark, NC 27709, US(51) MKPC07D 209/08 (2006.01) (97) EP 2049481 *C07D 231/56 (2006.01)C07D 235/08 (2006.01)C07D 263/56 (2006.01)C07D 401/04 (2006.01)C07D 417/04 (2006.01)C07D 471/04 (2006.01)C07D 487/04 (2006.01)A61K 31/33 (2006.01)A61P 3/04 (2006.01)(86) PCT/US2007075424 08.08.2007.(96) EP 07840765.7 08.08.2007.(87) WO2008021851, 21.02.2008. 200808(97) EP 2049481, 22.04.2009. 200917, En(31) 821853 P (32) 09.08.2006. (33) US(54) NOVEL COMPOUNDS AS ANTAGONISTS OR INVERSEAGONISTS FOR OPIOID RECEPTORSISSN 1331-2030